Unity Biotechnology, Inc.·4

Feb 3, 4:33 PM ET

Dananberg Jamie 4

4 · Unity Biotechnology, Inc. · Filed Feb 3, 2023

Insider Transaction Report

Form 4
Period: 2023-02-02
Dananberg Jamie
Chief Medical Officer
Transactions
  • Sale

    Common Stock, $0.0001 par value

    2023-02-02$4.84/sh863$4,17764,242 total
Footnotes (2)
  • [F1]Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F2]Includes Restricted Stock Units which vest over time measured from the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION